Global Vaccine Market Outlook (2007-2010)

Table of Contents

1. Analyst View

2. Research Overview

3. Vaccines - An Introduction

• 3.1 History
• 3.2 Vaccine Production Stages
  • 3.2.1 Cultivation
  • 3.2.2 Purification
  • 3.2.3 Quality Control
  • 3.2.4 Packaging
• 3.3 Vaccine Approval Process
  • 3.3.1 Phase I
  • 3.3.2 Phase II
  • 3.3.3 Phase III
  • 3.3.4 Phase IV
• 3.4 Regulatory Frameworks & Intellectual Property Rights
  • 3.4.1 Product Equals Process
  • 3.4.2 Regulatory Requirements
  • 3.4.3 Patent Protections
• 3.5 Types of Vaccine
  • 3.5.1 Live Attenuated Vaccines
  • 3.5.2 Killed Vaccines
  • 3.5.3 Toxoid Vaccines
  • 3.5.4 Component Vaccines
  • 3.5.5 Genetically Engineered Vaccines
  • 3.5.6 DNA Vaccines

4. Market Analysis

• 4.1 Global Vaccine Market

5. Industry Performance

• 5.1 Key Geographical Markets
  • 5.1.1 US
  • 5.1.2 Europe
  • 5.1.3 Japan
  • 5.1.4 China
  • 5.1.5 India
  • 5.1.6 Brazil
• 5.2 Major Vaccine Segments
  • 5.2.1 Basic Pediatrics
  • 5.2.2 Enhanced Pediatrics
  • 5.2.3 Proprietary Pediatrics
  • 5.2.4 Adult/Travel
  • 5.2.5 Therapeutics
    • 5.2.5.1 Cancer Vaccines
    • 5.2.5.2 Addiction Vaccines
  • 5.2.6 Influenza

6. Major Pediatric Vaccines

• 6.1 Pneumococcal Vaccines
• 6.2 Polio Vaccines
• 6.3 Varicella Vaccines
• 6.4 Meningitis Vaccines
• 6.5 Rotavirus Vaccines
• 6.6 DTP Vaccines
• 6.7 Measles, Mumps & Rubella (MMR) Vaccines
• 6.8 Tuberculosis Vaccines

7. Major Adult/Travel & Therapeutic Vaccines

• 7.1 Hepatitis B Vaccines
• 7.2 Malaria Vaccines
• 7.3 Japanese Encephalitis Vaccines
• 7.4 Ebola Vaccines
• 7.5 Cervical Cancer Vaccines
• 7.6 Typhoid Vaccines
• 7.7 West Nile Vaccines
• 7.8 HIV Vaccines

8. Industry Analysis

• 8.1 Market Drivers
  • 8.1.1 Diseases Prevention
  • 8.1.2 Higher Margins
  • 8.1.3 Increased Funding from Government & NGOs
  • 8.1.4 Government Regulations
  • 8.1.5 Blockbuster Potential of New Vaccines
  • 8.1.6 Increasing Population in Developing Countries
  • 8.1.7 Disease Awareness
• 8.2 Opportunities
  • 8.2.1 Contract Research
  • 8.2.2 Influenza Vaccine Segment
  • 8.2.3 India & China - Future Hub for Pediatric Vaccine Manufacturing
  • 8.2.4 Cancer Vaccine Segment
  • 8.2.5 Addiction Vaccine Segment
• 8.3 Challenges
  • 8.3.1 Huge R&D Cost
  • 8.3.2 Lack of Infrastructure for Trials & Manufactures
  • 8.3.3 Effective Vaccine Design
  • 8.3.4 Vaccine Supply
  • 8.3.5 Immunization Safety

9. Vaccine Market Players

• 9.1 Major Categories
  • 9.1.1 Vaccine Majors
  • 9.1.2 Vaccine-focused Biotech Companies
  • 9.1.3 Domestic-focused Vaccine Companies
• 9.2 Key Players
  • 9.2.1 Sanofi-Aventis
  • 9.2.2 GlaxoSmithKline Plc.
  • 9.2.3 Merck & Co., Inc.
  • 9.2.4 Novartis
  • 9.2.5 Wyeth

List of Figures:

• Figure 3-1: Vaccines Horizon* (1960 to 2010)
• Figure 4-1: Global - Vaccine Market (in Billion US$), 2003-2006E
• Figure 4-2: Global - Forecast for Vaccine Market (in Billion US$), 2007-2010
• Figure 5-1: Global - Vaccine Market Segmentation by Region (%), 2005
• Figure 5-2: Global - Sales Split of Major Vaccine Player by Region (%), 2004
• Figure 5-3: US - Vaccine Market (in Billion US$), 2003, 2006E, 2008E & 2013E
• Figure 5-4: US - Pediatric Vaccine Market (in Billion US$), 2003, 2006E, 2008E & 2013E
• Figure 5-5: US - Hepatitis Vaccine Market (in Million US$), 2003, 2006E, 2008E & 2013E
• Figure 5-6: US - Biodefense Vaccine Market (in Million US$), 2003, 2006E, 2008E & 2013E
• Figure 5-7: US - Influenza Vaccine Market (in Million US$), 2003, 2006E, 2008E & 2013E
• Figure 5-8: US - Travel Vaccine Market (in Million US$), 2003, 2006E, 2008E & 2013E
• Figure 5-9: US - Developmental Vaccine Market (in Million US$), 2008E & 2013E
• Figure 5-10: Europe - Vaccine Market (in Billion US$), 2005, 2006E, 2008E & 2012E
• Figure 5-11: Japan - Influenza Vaccine Production (in Million Units), 2004-05, 2005-06 & 2006-07E
• Figure 5-12: China - Vaccine Market (in Billion RMB) 2004-2006E
• Figure 5-13: China - Forecast for Vaccine Market (in Billion RMB) 2007-2010
• Figure 5-14: India - Vaccine Market (in Million US$) 2004-05 to 2008-09E
• Figure 5-15: India - Share of Public & Private Sectors in Vaccine Market (%), Nov 2006
• Figure 5-16: India - Top 6 Selling Drugs in Vaccine Market (in Rs Crore), 2005-06
• Figure 5-17: India - Share of Domestic Consumption & Exports in Vaccine Market (%), 2005-06
• Figure 5-18: Brazil - Vaccine Market (in Million BRL), 2000, 2004, 2006E & 2008E
• Figure 5-19: Brazil - Share of Public & Private Sectors in Vaccine Market (%), 2000
• Figure 5-20: Global - Vaccine Market by Segment (in Billion US$), 2005, 2006E & 2010E
• Figure 5-21: Global - Share of Vaccine Market by Segment (%), 2005, 2006E & 2010E
• Figure 5-22: Global - Basic Pediatrics Vaccine Market (in Billion US$), 2005 & 2006E
• Figure 5-23: Global - Forecast for Basic Pediatrics Vaccine Market (in Billion US$), 2007-2010
• Figure 5-24: Global - Enhanced Pediatrics Vaccine Market (in Billion US$), 2005 & 2006E
• Figure 5-25: Global - Forecast for Enhanced Pediatrics Vaccine Market (in Billion US$), 2007-2010
• Figure 5-26: Global - Proprietary Pediatrics Vaccine Market (in Billion US$), 2005 & 2006E
• Figure 5-27: Global - Forecast for Proprietary Pediatrics Vaccine Market (in Billion US$), 2007-2010
• Figure 5-28: Global - Adult/Travel Vaccine Market (in Billion US$), 2005 & 2006E
• Figure 5-29: Global - Forecast for Adult/Travel Vaccine Market (in Billion US$), 2007-2010
• Figure 5-30: Global - Therapeutics Vaccine Market (in Billion US$), 2005 & 2006E
• Figure 5-31: Global - Forecast for Therapeutics Vaccine Market (in Billion US$), 2007-2010
• Figure 5-32: Global - Cancer Vaccine Market (in Billion US$), 2005, 2008E & 2010E
• Figure 5-33: Global - Addiction Vaccine Market (in Million US$), 2008E & 2010E
• Figure 5-34: Global - Influenza Vaccine Market (in Billion US$), 2005 & 2006E
• Figure 5-35: Global - Share of Influenza Vaccine Production by Manufacturer (%), 2006
• Figure 5-36: Global - Forecast for Influenza Vaccine Market (in Billion US$), 2007-2010
• Figure 6-1: Global - Pneumococcal Vaccine Market (in Billion US$), 2006 & 2010E
• Figure 6-2: Global - Number of Polio Incidences (2004-2006)
• Figure 6-3: Global - Countries with Maximum Number of Polio Incidences, 2006
• Figure 6-4: Global - Polio Vaccine Market (in Million US$), 2004 & 2011E
• Figure 6-5: Global - Inactivated Polio Vaccine Doses (in Million), 2006 & 2011F
• Figure 6-6: Global - Meningitis Vaccine Market (in Billion US$), 2004 & 2010E
• Figure 6-7: Global - Forecast for Rotavirus Vaccine Market (in Billion US$), 2010
• Figure 6-8: Global - Forecast for Rotavirus Vaccine Market Segmentation by Region (%), 2010
• Figure 6-9: Global - Number of Diphtheria Incidences by Region, 2006
• Figure 6-10: Global - Number of Pertussis Incidences by Region, 2006
• Figure 6-11: Global - Number of nTetanus Incidences by Region, 2006
• Figure 6-12: Global - Number of tTetanus Incidences by Region, 2006
• Figure 6-13: Global - Share of DTP Combos Market by Player (%), 2004
• Figure 6-14: Global - Number of Measles Incidences by Region, 2006
• Figure 6-15: Global - Number of Mumps Incidences by Region, 2006
• Figure 6-16: Global - Number of Rubella Incidences by Region, 2006
• Figure 6-17: Global - Number of Tuberculosis Incidences (in Thousand), 2005
• Figure 7-1: Global - Hepatitis B Surface Antigen Prevalence (%), 2005
• Figure 7-2: Global - Hepatitis B Vaccine Market (in Million US$), 1999, 2005, 2006 & 2011F
• Figure 8-1: Global - Profit Margins of Vaccines, Generics & Branded Drugs (%), 2007E
• Figure 8-2: Global - Sources of Financing for Vaccine Market (%), 2001
• Figure 8-3: Global - Prevnar Sales (in Million US$), 2003-2006
• Figure 8-4: US - Drug Discovery Contract Research Organization Market (in Billion US$), 2006E & 2013E
• Figure 8-5: Global - Dose Consumption & Revenue by Income of Region (%), 2005
• Figure 9-1: Global - Share of Vaccine Market by Player (%), 2005

List of Tables:

• Table 5-1: China - Vaccines Classification
• Table 5-2: China - Pediatric Vaccine Requirement (in Million Doses)
• Table 5-3: Brazil - Public & Private Sectors Vaccine Market (in Million BRL), 2000
• Table 7-1: Global - Number of HIV/AIDS Patients (in Million), 2006
• Table 8-1: Global - Number of Deaths due to Diphtheria Averted by Vaccines (in Thousand), 2001
• Table 8-2: Global - Cumulative Confirmed Human Cases & Number of Deaths due to Avian Influenza A/ (H5N1), 2003-2007
• Table 9-1: Global - Share of Vaccines in Total Pharma Sales of Major Players (%), 2005
• Table 9-2: Global - Growth of Vaccines Segment of Major Pharma Players (%), 2005
• Table 9-3: Global - Overall Growth of Major Pharma Players (%), 2005
• Table 9-4: Global - Major Vaccine Companies (Segmentation by Revenue)
• Table 9-5: Sanofi-Aventis - Key Financials (in Million US$), 2004-2006
• Table 9-6: GlaxoSmithKline Plc. - Key Financials (in Million US$), 2004-2006
• Table 9-7: Merck & Co., Inc. - Key Financials (in Million US$), 2004-2006
• Table 9-8: Novartis - Key Financials (in Million US$), 2004-2006
• Table 9-9: Wyeth - Key Financials (in Million US$), 2004-2006